Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
申请人:Fujifilm Ri Pharma Co., Ltd.
公开号:US08022075B2
公开(公告)日:2011-09-20
To provide a diagnostic drug which binds specifically to an amyloid aggregate and/or an amyloid deposit, to thereby realize imaging and quantification of a disease caused by amyloid aggregation and/or deposition.
The invention provides a compound represented by formula (1):
(wherein X1 represents an optionally substituted bicyclic heterocyclic group;
X2 represents a hydrogen atom, a halogen atom, or a chelate-forming group;
ring A represents a benzene ring or a pyridine ring; and
ring B represents an optionally substituted 5-membered aromatic heterocyclic group which is bonded to the benzene ring or the pyridine ring via a carbon atom of ring B), a salt thereof, a solvate of any of these, or a transition metal coordination compound of any of these, and a diagnostic, preventive, or therapeutic drug containing the same.
提供一种特异性结合到淀粉样聚集体和/或淀粉样沉积物的诊断性药物,从而实现淀粉样聚集和/或沉积引起的疾病的成像和定量。本发明提供了由式(1)表示的化合物:(其中X1代表可选取代的双环杂环基;X2代表氢原子,卤素原子或螯合形成基团;环A代表苯环或吡啶环;环B代表可选取代的5-成员芳香杂环基,通过环B的碳原子与苯环或吡啶环连接),其盐,任何这些的溶剂化合物或过渡金属配合物,以及含有该化合物的诊断性、预防性或治疗性药物。